Herpes zoster vaccination efficacy in adults 70 years of age or older: ZOE-70 study

被引：0
|
作者：
Salzberger B. [1 ]
Nitschmann S. [2 ]
机构：
[1] Stabstelle Infektiologie, Universitätsklinikum Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg
来源：
Der Internist | 2017年 / 58卷 / 5期
关键词：
D O I：
10.1007/s00108-017-0222-3
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：522 / 524
页数：2
相关论文
共 50 条
  • [1] Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
    Cunningham, A. L.
    Lal, H.
    Kovac, M.
    Chlibek, R.
    Hwang, S. -J.
    Diez-Domingo, J.
    Godeaux, O.
    Levin, M. J.
    McElhaney, J. E.
    Puig-Barbera, J.
    Abeele, C. Vanden
    Vesikari, T.
    Watanabe, D.
    Zahaf, T.
    Ahonen, A.
    Athan, E.
    Barba-Gomez, J. F.
    Campora, L.
    de Looze, F.
    Downey, H. J.
    Ghesquiere, W.
    Gorfinkel, I.
    Korhonen, T.
    Leung, E.
    McNeil, S. A.
    Oostvogels, L.
    Rombo, L.
    Smetana, J.
    Weckx, L.
    Yeo, W.
    Heineman, T. C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (11): : 1019 - 1032
  • [2] Efficacy, Immunogenicity and Safety of adjuvanted Herpes Zoster-Virus Subunit Vaccine Candidates in Adults from 60 Years and older: Results from the Efficacy Studies ZOE-50 and ZOE-70
    McElhaney, Janet
    Lal, Himal
    Cunningham, Anthony
    Levin, Myron
    Chlibek, Roman
    Diez-Domingo, Javier
    Athan, Eugene
    Berglund, Johan
    Downey, Jackson
    Ghesquiere, Wayne
    Godeaux, Olivier
    Gorfinkel, Iris
    Hwang, Shinn-Jang
    Korhonen, Tiina
    McNeil, Shelly
    Pauksens, Karlis
    Puig-Barbera, Joan
    Avelino-Silva, Thiago
    Vesikari, Timo
    Volpi, Antonio
    Watanabe, Daisuke
    Yeo, Wilfried
    Campora, Laura
    Vanden Abeele, Carline
    Oostvogels, Lidia
    Heinemann, Thomas
    Hain, Johannes
    INTERNIST, 2018, 59 : S64 - S65
  • [3] Effectiveness of Herpes zoster Vaccination for 70 years old
    Salzberger, B.
    Nitschmann, S.
    INTERNIST, 2017, 58 (05): : 522 - 524
  • [4] The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials
    Kim, Joon Hyung
    Diaz-Decaro, John
    Jiang, Ning
    Hwang, Shinn-Jang
    Choo, Eun Ju
    Co, Maribel
    Hastie, Andrew
    Hui, David Shu Cheong
    Irimajiri, Junya
    Lee, Jacob
    Leung, Edward Man-Fuk
    Tang, Haiwen
    Tsuru, Tomomi
    Watson, Philip
    Wu, Zhenhua
    Yu, Chong-Jen
    Yuan, Yanfei
    Zahaf, Toufik
    Cunningham, Anthony L.
    Schuind, Anne
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (07) : 2050 - 2057
  • [5] In adults ≥ 70 years of age, an adjuvanted herpes zoster subunit vaccine reduced herpes zoster at a mean 3.7 years
    Sacks, Henry S.
    ANNALS OF INTERNAL MEDICINE, 2017, 166 (02) : JC5 - JC5
  • [6] ZOE-50 and ZOE-70 placebo groups data shows that burden of pain associated with herpes zoster interferes with activities of daily living
    Cunningham, Anthony L.
    Cabrera, Eliazar Sabater
    Curran, Desmond
    Matthews, Sean
    Boutry, Celine
    Lecrenier, Nicolas
    AUSTRALASIAN JOURNAL ON AGEING, 2022, 41 : 39 - 39
  • [7] Efficacy of the Herpes Zoster Subunit Vaccine in Adults 65 Years of Age or Older
    McElhaney, J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 : S12 - S12
  • [8] The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70
    Boutry, Celine
    Hastie, Andrew
    Diez-Domingo, Javier
    Tinoco, Juan Carlos
    Yu, Chong-Jen
    Andrews, Charles
    Beytout, Jean
    Caso, Covadonga
    Cheng, Huey-Shinn
    Cheong, Hee Jin
    Choo, Eun Ju
    Curiac, Dan
    Di Paolo, Emmanuel
    Dionne, Marc
    Eckermann, Tamara
    Esen, Meral
    Ferguson, Murdo
    Ghesquiere, Wayne
    Hwang, Shinn-Jang
    Avelino-Silva, Thiago Junqueira
    Kosina, Pavel
    Liu, Chiu-Shong
    Markkula, Jukka
    Moeckesch, Beate
    de Oliveira, Claudia Murta
    Park, Dae Won
    Pauksens, Karlis
    Pirrotta, Paola
    Plassmann, Georg
    Pretswell, Carol
    Rombo, Lars
    Salaun, Bruno
    Berglund, Johan Sanmartin
    Schenkenberger, Isabelle
    Schwarz, Tino
    Shi, Meng
    Ukkonen, Benita
    Zahaf, Toufik
    Zerbini, Cristiano
    Schuind, Anne
    Cunningham, Anthony L.
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (08) : 1459 - 1467
  • [9] Safety of the adjuvanted recombinant zoster vaccine in adults aged 50 years or older. A phase IIIB, non-randomized, multinational, open-label study in previous ZOE-50 and ZOE-70 placebo recipients
    Ocran-Appiah, Josephine
    Boutry, Celine
    Herve, Caroline
    Soni, Jyoti
    Schuind, Anne
    VACCINE, 2021, 39 (01) : 6 - 10
  • [10] The Adjuvanted Recombinant Zoster Vaccine (RZV) Confers Long-term Protection Against Herpes Zoster: Interim Results of an Extension Study (ZOSTER-049) of Two Clinical Trials (ZOE-50 and ZOE-70)
    Lindenberg, Sandra
    Boutry, Celine
    Hastie, Andrew
    Shi, Meng
    Diez-Domingo, Javier
    Tinoco, Juan Carlos
    Yu, Chong-Jen
    Pirrotta, Paola
    Kalema, George
    Schuind, Anne
    INTERNIST, 2021, 62 (SUPPL 2): : 167 - 168
12345